TY - JOUR
T1 - A clinical study on residue and recurrence after endoscopic mucosal resection for early gastric mucosal carcinoma
AU - Muto, Manabu
AU - Saito, Yasutoshi
AU - Koike, Tomoyuki
AU - Iijima, Katsunori
AU - Kamiya, Takanori
AU - Ikeya, Shinichi
AU - Sasaki, Takashi
AU - Hoshino, Eiji
AU - Mochizuki, Mamoru
N1 - Funding Information:
Coca reports personal fees and other from RenalytixAI, personal fees from CHF Solutions, personal fees from Quark, personal fees from Takeda, personal fees from Janssen, personal fees and “other” from pulseData, and personal fees from Goldfinch, outside the submitted work. Nadkarni reports personal fees from Renalytix AI, from Pensieve Health, personal fees from BioVie, and grants from Goldfinch Bio, outside the submitted work.
PY - 1996
Y1 - 1996
N2 - To clarify the clinical management of histological margin positive cases after endoscopic mucosal resection (EMR) for early gastric cancer, we analyzed the therapeutic effect of additional treatment and the frequency of residue or recurrence after EMR in histologically incomplete resection cases. EMR was done for 91 cases in our hospital. 66 cases could be follow up and estimated for this study. As additional treatments for histologically incomplete resection cases, surgical resection was performed in 6 cases, laser irradiation was done in 9 cases, and electrocautery was done in 13 cases. Histologically, cancer remnant were not seen in any surgical resected specimens. Among 22 cases who received endoscopic additional treatment because of histological positive margin, residue of the cancer was demonstrated in two cases (9.1%). However, in 38 cases who showed histological negative margin, no cases was found to have residue or recurrnce. We conclude that immediate endoscopic additional treatment was effective for reducing the rate of residue and recurrence in the cases of histological positive margin after EMR.
AB - To clarify the clinical management of histological margin positive cases after endoscopic mucosal resection (EMR) for early gastric cancer, we analyzed the therapeutic effect of additional treatment and the frequency of residue or recurrence after EMR in histologically incomplete resection cases. EMR was done for 91 cases in our hospital. 66 cases could be follow up and estimated for this study. As additional treatments for histologically incomplete resection cases, surgical resection was performed in 6 cases, laser irradiation was done in 9 cases, and electrocautery was done in 13 cases. Histologically, cancer remnant were not seen in any surgical resected specimens. Among 22 cases who received endoscopic additional treatment because of histological positive margin, residue of the cancer was demonstrated in two cases (9.1%). However, in 38 cases who showed histological negative margin, no cases was found to have residue or recurrnce. We conclude that immediate endoscopic additional treatment was effective for reducing the rate of residue and recurrence in the cases of histological positive margin after EMR.
UR - http://www.scopus.com/inward/record.url?scp=0345885440&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0345885440&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0345885440
SN - 0387-1207
VL - 38
SP - 1011
EP - 1019
JO - Gastroenterological Endoscopy
JF - Gastroenterological Endoscopy
IS - 4
ER -
